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Subsequent hematologic and bacteriologic study by numerous investigators demonstrated that human leukemia in none of its forms could be related to any definitive bacterial, animal parasitic, or filterable agent. Much of the descriptive pathological work has centered about the classification of this intriguing disease; what is its relation to the neoplasms (lymphosarcoma, leukosarcoma, multiple myeloma), the atypical granulomata (Hodgkin's disease, mycosis fungoides), and the hyperplastic hemopoietic responses to infectious agents? In the century following the original descriptions progress has been made in the classification of the morphological and clinical types of the disease, but little more is known concerning its etiology than when Bennett and Virchow first recognlized leukemia as a distinct entity.
The first step in leukemia investigations beyond the descriptive phase was made by Ellerman"5 in 1908 , when he demonstrated that fowl leukemia can be transmitted to normal chickens by inoculation of either leukemic cells or cell-free filtrates derived from the blood or tissues of leukemic animals. Subsequent investigations confirmed this pioneer work. The neoplastic nature of chicken leukemia is now rather generally accepted; Ellerman was, unknown to himself, among the first to transfer a neoplasm to a new host by inoculation of cell-free extracts of neoplastic tissues.
In 1926-27 Snijders89 and Tio Tjwan Gie,95 in Holland, descrilbed leukemia and lymphosarcoma in the guinea-pig and demonstrated that these diseases can be transferred to susceptible animals only by inoculation of intact leukemic or sarcomatous lymphocytes. Unlike the situation in the chicken, inoculations of cell-free filtrates did not transmit the disease. It was concluded that the cells introduced gave rise to all the cells of the leukemic process in the new host; the latter's tissues produced none of the malignant or leukemic lymphocytes.
Richter and MacDowell8" reported the experimental transmission of leukemia in the C58 strain of mice in 1929. Since this date the bulk of the work in experimental leukemia has been done on the mouse. Three inbred strains of mice (C58, Ak, and F) exhibiting a high incidence of spontaneous leukemia, various sublines of strain dba in which leukemia can be induced readily with carcinogens, and several low-leukemia strains in which leukemia develops after administration of x-rays or estrogens, are being investigated in this country. These mice represent excellent material for controlled studies on leukemia and lymphosarcoma in this species.
The nature of mouse leukemnia Leukemia in the mouse is similar to human leukemia morphologically and clinically. Bone-marrow and blood smears, and tissue sections of mouse lymphatic leukemia are indistinguishalble from similar preparations of the human disease. 25' 46, 86 The spontaneous diseases of both species are invariably fatal and react in the same way to x-irradiation. After treatment dinical improvement might be evident, but there is ultimately an acute exacerbation of the disease. "7 Since the members of a strain of mice are so closely related, tissue grafts are to be considered practically autologous. Consequently, leukemic lymphocytes or granulocytes can be inoculated into mice of the same strain and remain viable. They not only survive, but proliferate and consistently give rise to leukemia in the new host. When inoculated subcutaneously leukemic cells form a tumorous nodule; from this they metastasize to various organs of the host.
The tissue of the inoculated animal does not proliferate any of the leukemic cellS. 29' 46, 81 In the light of these experiments in a species where leukemia is decidedly similar to, if not identical with, human leukemia, the classical concept of the diffuse origin of leukemic cells from the gen-eral mesenchymal tissue of the human has been subjected to criticism. 25 The theory of diffuse "local" rather than "infiltrative" origin of leukemic lesions has been used, for obscure reasons, as an argument in favor of "hyperplasia" as opposed to "neoplasia." In the first place, multicentric origin would be compatible with the neoplastic concept of leukemia, and second, it is doubtful that human leukemic lesions are all local in origin from the mesenchyme or reticulum of the organ involved. In terminal cases (and this is the type of material from which most deductions have been made) it is not possible objectively to make the distinction between "in situ" origin of cells and "infiltration." In the mouse "systemic leukemia," so-called, can result from a single focus of transplanted cells without origin of leukemic cells from the host itself; Furth and Kahn28 introduced a single cell into susceptible mice with, in several instances, the ultimate development of uniformly widespread leukemic lesions.
Potter, Victor, and Ward83 have observed what they interpret as preleukemic reticulo-endothelial proliferations of the interfollicular tissue of mouse lymph nodes and the loose connective tissue surrounding the central veins of the liver. These lesions did not prove to be widespread within any one mouse. In mice of the C58 strain the first external evidence of the imminent development of spontaneous leukemia is, in many cases, a single enlarged lymph node. Such lymph nodes were excised and inoculated as cellular suspensions intraperitoneally into normal young (preleukemic age group) mice of the same strain.9" These animals developed transplanted leukemia shortly after inoculation, whereas the donor did not become leukemic until a significantly later date, that is, until a new focus of reticulo-endothelial proliferation appeared.
Systemic leukemia can, according to the above investigators, arise from a single neoplastic focus in the mouse. A single localized area of lymphoid neoplasia could thus produce as an end-result either leukemia or lymphosarcoma, depending on the invasive character of the cells proliferated from the reticulo-endothelial mother tissue. Some malignant lymphocytes, for example, are able to enter the blood stream readily, colonize throughout the body, and give rise to "systemic leukemia"; other more infiltrative lymphocytes enter the blood stream to a lesser extent, and when they do so they produce infiltrating lymphosarcomatous growths at the points of escape from the capillaries. Some sarcomatous lymphocytes fail to survive when injected into the blood stream of a host susceptiible to extra-vascular inoculation of the same cells.43 Many lines* of leukemic and sarcomatous lymphocytes exhibiting varying degress of infiltrative and metastatic capability have been studied. Those which produce large tumors when inoculated subcutaneously invade the blood stream less readily than do those which produce very small flat tumors. 25 29, 43 The type of growth produced by leukemic cells depends on the host in which the cells proliferate as well as on the intrinsic cellular physiology. Previous irradiation of an animal29 or partial immunization62 may determine the sarcomatous or leukemic nature of inoculated cells.
Mouse leukemia with multicentric foci of origin has appeared following the administration of carcinogens."9 This finding is in keeping with the neoplastic nature of leukemia in this species; induced lung tumors are usually multiple, and there were literally hundreds of foc of neoplastic activity in the mammary glands of strain diba female breeders which had been skin-painted with methycholanthrene dissolved in benzene. the basiphilic lymphocytes which are found in increased number in the peripheral blood of some leukemias. The general pattern of hemopoiesis rather than individual cellular morphology is of prime importance in diagnosis. In certain instances benign myeloid metaplasia in the mouse may be indistinguishable morphologically from myeloid leukemia,3 and transplantation studies must be resorted to as a physiological test for malignancy. In the human the same problem has arisen in distinguishing between benign and leukemic extramedullary hemopoiesis.
Experiments on the mouse have confirmed the impressions of most pathologists concerning the neoplastic nature of leukemia. The view has been expressed that chronic leukemias are hyperplastic, whereas acute leukemias might be neoplastic.9" A chronic leukemia of the mouse can, however, be transformed into an acute leukemia by passage through numerous hosts. 25 48 , 50 but decreased the total incidence of the disease, since many mice died of neoplasms other than leukemia. The carcinogenic hydrocarbon, 1,2,-5,6-dibenzanthracene, in general a less potent carcinogen than benzpyrene or methylcholanthrene, proved not to be leukemogenic for the F strain. Several strains of mice (NH, C57, CHI, A,) with a low incidence of spontaneous leukemia failed to respond to the leukemiainducing activity of carcinogens.41 48 50 On the other hand, some low-leukemia strains (Swiss, Rf, C3H, Buffalo) developed a high leukemia incidence following treatment with carcinogenic chemicals.52, 7' Genetic susceptibility to the leukemogenic activity of carcinogens would seem not to be synonymous with susceptibility to the development of spontaneous leukemia, although there seems to be some degree of positive correlation. Carcinogens may induce in mice susceptible to spontaneous leukemia a malignant lymphoid or myeloid deviation unrelated genetically to the spontaneous leukemic transformation.21' 87 The route of administration and the solvent of the carcinogen can determine its effectiveness as a leukemogenic agent. For the F strain methylchiolanthrene was leukemogenic when dissolved in benzene and applied percutaneously; when administered in the same fashion dissolved in sesame oil its leukemia-inducing potency was lost.41 The presence of cotton-seed oil on the fur of the mice fed a high-fat diet probably was the factor resulting in prolongation of the period of carcinogenic induction when methylcholanthrene dissolved in benzene was applied percutaneously.5 Intravenous injection of methylcholanthrene suspended in horse serum induced mammary cancer but not leukemia in the F strain. 48 The leukemogenic activity of methylcholanthrene for the dba strain was enhanced when the solvent was ibenzol rather than acetone, the route of administration being percutaneous.71 In the F strain, mice which did not develop skin tumors readily following the percutaneous application of carcinogens were more susceptible to the induction of leukemia than were those which developed skin papillomas and carcinomas relatively early.48 The incidence of carcinogen-induced leukemia was reduced in dba females of sub-line 12 which were allowed to breed and which developed mammary cancer during the course of treatment with carcinogens.44
Estrogens: Gardner and his associates31, 32 demonstrated that the incidence of leukemia in certain low-leukemia strains was increased appreciably when estrogenic hormone was administered in relatively large doses over a long period of time. Mice of certain strains, and especially the females in some stocks, were more susceptible than were others.31 Generalized osteosclerosis was associated with the development of leukemia. The development of both osteosclerosis and leukemia could be inhibited if androgenic hormone was given in appropriate quantity simultaneously with the estrogen.
A higher incidence of leukemia has been noted in the females of certain strains.'2 Ovariectomy resulted in a decreased leukemia incidence in the high-leukemia Ak strain; following orchidectomy the incidence was slightly elevated.70 Such an influence of endogenous estrogen was not suggested in the case of induced leukemia in strain dba71 or spontaneous leukemia in strain F. 40 Ovarieotomy did not inhibit the spontaneous development of leukemia in strain F mice; the adrenals of the castrate animals were not adenomatous and did not serve as a source of estrogenic hormone. X-rays: The incidence of leukemia has been reported to be higher in x-ray workers than in the general population.34 ' Krebs and his associates 5 observed an increased incidence of leukemia among pen-bred mice exposed to x-rays. Because of the lack of adequate controls of similar genetic background to the test animals, this work cannot be considered reliable. The first adequately controlled experiments indicating the leukemogenic action of x-rays were those of Furth,"9 in which the incidence of leukemia was increased threefold within an inbred strain by exposure to x-rays. The incidence of myelogenous leukemia, especially, was elevated. Furth and Boon22 have demonstrated also that x-rays can act synergistically with the carcinogenic hydrocarbons if the test mice are susceptible to the induction of leukemia with each of the agents administered singly. This synergism was not demonstrable for strain dba; the susceptibility of these mice to the leukemogenic action of methylcholanthrene was not altered by previous exposure to x-rays. 38 The genetic constitution of the mouse conditions its reaction to x-rays. In some strains leukemia can be induced by this physical agent, whereas other strains are resistant to its leukemogenic action. Susceptibility to the induction of leukemia with x-rays cannot be correlated with susceptibility to spontaneous leukemia or to the leukemogenic action of carcinogens.37 Strain dba proved susceptible to the carcinogenic induction of leukemia, but leukemia was not precipitated 'by exposure to x-rays. On the other hand, strain A mice are resistant to both spontaneous and carcinogenic induction of leukemia, but they are susceptible to the induction of leukemia by x-rays.
Benzol: It has been stated often in the literature that exposure to benzol can result in the development of leukemia in the human subject. Lignac reported the induction of leukemia in market mice by the periodic injection subcutaneously of benzol dissolved in olive oil.59 Although benzol proved to favor the leukemogenic activity of methylcholanthrene when used as a solvent for this carcinogen (as compared with acetone as a vehicle), benzol alone was probably not leukemogenic for the dba strain.7' Percutaneous application of 48 benzol did not accelerate the onset of leukemia in the F strain. To establish definitely the diagnosis of leukemia in mice the disease should be transferred by inoculation of viable cells into susceptible mice. Unless mice of known genetic constitution are used in experiments on the induction of leukemia the results are open to question, since leukemia occurs spontaneously in market mice. It would seem that the leukemogenic action of benzol has not been demonstrated conclusively experimentally; it is possible, however, that it induces leukemia in animals of the appropriate genetic constitution.
Miscellaneous agents have been said to be leukemogenic.5 11 Proper evaluation of such studies must await further experimentation on mice and rats of inbred strains where the age incidence of leukemia among controls is known. Because of the association of infection with leukemia (probably as a result of decreased resistance secondary to leukemia) it is desirajble that bacteria and their toxins be studied experimentally under controlled conditions as precipitating agents for leukemia. Purpura, elevated temperature, acute onset with prostration, and increased metabolic rate have prejudiced many clinicians in favor of the idea that leukemia is an atypical response to an infectious agent. There are no supporting epidemiological studies, nor have Koch's postulates been satisfied for any of the bacterial agents isolated from cases of leukemia.
It has been postulated that there is a substance in the urine of patients with myelogenous leukemia which produces hyperplasia of the bone marrow and extramedullary hemopoiesis when injected into guinea-pigs; extracts of urine from patients with lymphatic leukemia or multiple myeloma are said to have produced hyperplasia of the lymphoid elements.100
In general, it might be concluded that various agents are effective in inducing leukemia or in accelerating its onset depending on the genetic constitution of the mice used for experimentation. Because a strain of mice is susceptible to the action of one such agent does not imply necessarily that the animals are susceptible to another agent which has been shown to be leukemogenic for still another strain. Genetics of mouse leukemia MacDowell and Richter found that the incidence of leukemia in hybrids could be roughly correlated with the total heredity from the high-leukemia C58 strain when C58 hice were crossed with low-leukemia StoLi animals.6 A "maternal influence" was suggested, for if the female parent was of the C58 strain the incidence of leukemia was 20 per cent greater than in the reciprocal cross. Cole and Furth 12 working with the Ak and Rf stocks, concluded that susceptibility to leukemia is probably inherited as a multiple-factor character, and is influenced by undetermined environmental factors. In various crosses the common logarithm of the per cent leukemia was a simple function of the per cent heredity from the high-leukemia stock. Female mice had a higher incidence of leukemia than had males. It was concluded that the genetic basis for spontaneous leukemia may vary for different stocks of mice, since Mercier73 had observed that susceptibility to spontaneous lymphosarcoma was inherited as a simple Mendelian recessive character, and the results of MacDowell and Richter were somewhat at variance with those of Cole and Furth.
In later experiments with the Ak stock, Furth, Boon, and Kaliss2" found that when animals of this stock were crossed with the C3H rather than With the Rf stock the incidence of leukemia in the F1 hybrids was higher; if the female parent was of the C3H strain the incidence of leukemia was 50 per cent, as compared with an incidence of 34 per cent in the reciprocal cross.
When the high-leukemia F strain was crossed with three lowleukemia stocks (CBA, A, and C57), the incidence of leukemia in F, hybrids and in 'backcrosses to the high-leukemia stock was approximately the same as in the pure F stock. 40 In the backcross population to the low-leukemia stock the incidence of leukemia was probably reduced, although a high percentage of the animals of this group died of other causes (polycystic kidney disease and mammary cancer), thus complicating the picture.
The most significant finding in hybrid animals was the delayed appearance of leukemia (as compared with animals of the pure F stock). The data of other workers indicate that the same was true in their studies. '12 65 The delay in the appearance of leukemia and lymphosarcoma could be correlated with (1) the degree of inheritance from the F strain and/or (2) the increased life expectancy in hybrids. The latter, however, seemed to depend to some extent on the strain F genic contribution. For example, life expectancy was greater in F, hybrids than in backcrosses to the F strain. Leukemia appeared in approximately the same percentage in both groups, but the onset was later in the F, hybrids. Thus, with a greater life expectancy leukemia appeared later in life. Life expectancy was no greater, however, in backcrosses to the low-leukemia stock than in F, hybrids. Still, the onset of leukemia seemed to be delayed as compared with the F, hybrids. This would suggest a direct correlation between the age of appearance of leukemia and the quantitative genic contribution from the F strain; the greater the number of strain F genes in a hybrid animal, the earlier leukemia appeared. For the heterogeneous F2 population the appearance of leukemia was scattered through the various age groups. MacDowell observed a maternal influence for longevity; F, hybrid mice receiving this influence from the low-leukemia strain developed leukemia later in life than did F, hybrids of the reciprocal cross.6" It is possible that hybrid animals possess a greater degree of resistance towards the unknown causative "agent" of mouse leukemia, and consequently the disease appears later in life and in a more chronic form. With an increased life expectancy metabolic differences might be expected to delay the onset and alter the character of neoplastic change.
In determining the incidence of leukemia in hybrid animals it is of utmost importance that intercurrent infection and the appearance of other neoplasms be reduced to a minimum, and that environmental conditions be optimal so that sufficient time is given for the genetic capability to become manifest. Unless these factors are equally controlled in all experiments, the data of independent investigators are not comparable.
Although mice of strain dba develop leukemia when skin-painted with carcinogenic hydrocarbons, F, hybrids resulting from a cross between dba males and C3H females (with or without the mammary cancer milk-influence) did not become leukemic when similarly treated.4" Either susceptibility to carcinogenic induction of leukemia in this strain is inherited as a recessive character, or in hybrids the latent period of induction is prolonged to such an extent that the animals die first of skin tumors, or perhaps a milk-influence from dba female mice conditions the response to methylcholanthrene. The last possibility is now being tested. Methylcholanthrenetreated F1 hybrid females developed mammary cancer precociously if they were bred and the female C3H parent provided the mammary cancer milk-influence. The foregoing discussion has dealt with the genetics of the host. As in the case of other types of mouse neoplasia, the atypical cells of leukemia are probably mutants. 41 92 Susceptibility to transplanted tissue depends on the genetic compatibility of tissue and host recipient. In general, neoplasms grow in the strain of origin and in F1 hybrids. A varying percentage of F2 hybrids do not grow inoculated cells, but those resistant to one spontaneous neoplasm will, in many cases, grow a second spontaneous tumor of the same strain. This has been shown to be the case for leukemia. If transplantability depends on the genetic constitution of transplanted cells and host, and if the host remains constant, then the conclusion is that the genetic constitution of the individual leukemias varies. Whether the genic difference is the cause or the result of neoplasia has not been proved. Furth and Barnes2' have found that the induced leukemias of hybrid animals have a different transplantation pattern from that of spontaneous leukemias in the same animals; the carcinogen has not merely accelerated a spontaneous process but has induced a new neoplasm with the accompanying cellular mutation.
Non-genetic influences and spontaneous leukemia Maternoal influence: It has been established than an "influence" contained in the breast-milk of high-mammary-cancer strains is important in determining the development of mammary cancer in these stocks.6 MacDowell and Richter reported 61, 65 what seemed to be a similar although less marked "maternal influence" with reference to leukemia, the high-leukemia C58 strain and the low-leukemia StoLi strain being reciprocally crossed in their studies. Original foster-nursing experiments failed to demonstrate any milkinfluence. However, later experiments revealed that the incidence of leukemia was higher in genetically identical mice foster-nursed by Bagg-albino rather than by StoLi mice. 68 In both of these strains leukemia occurs only rarely. Although albino females had a more potent influence on the incidence of leukemia than had StoLi nurses, nurses from the high-leukemia strain had a still greater influence than the albinos.
Barnes and Cole2 observed a decreased incidence of leukemia in mice of a high-leukemia stock (Ak) fostered by females of low-leukemia stocks (Af and Rf). Fostered animals died relatively early, however, from intercurrent disease. Furth, Cole, and Boon' obtained results similar to those of MacDowell and Richter with respect to the incidence of leukemia in F1 hybrids, that is, the incidence of leukemia was greater in F1 hy,brids whose mothers were of the high-leukemia (Ak) rather than of the low-leukemia (C3H-high-mammary-cancer) stock. The effect was more pronounced in males. It was also found that foster-nursing by low-leukemia ('but high-mammary-cancer) females significantly lowered the incidence of leukemia in the high-leukemia stock. However, the offspring of the fostered mice developed leukemia to as great a degree as the original leukemic stock. The incidence of mammary cancer, on the other hand, is low in the offspring of fostered mice of a high-mammary-cancer strain.6 Since the high-mammary-cancer C3H females were used in foster-nursing, the milk-influence of mammary cancer and of leukemia would seem to be different.
There was nothing to indicate that a specific "milk-influence" (as for mammary cancer) was concerned in the development of leukemia in the F strain of mice. 49 The total and age incidences of leukemia were not significantly different in the two groups of F1 hybrids obtained by reciprocally crossing strain F with low-leukemia animals. When F1 hybrids were backcrossed to high-(strain F) and low-(strains A and CBA) leukemia strains in such a manner that strain F influence was supplied entirely by the male, the incidence of leu-kemia was at least as high as when only strain F females were used in breeding to obtain F2 hybrids.
In addition, strain F mice were foster-nursed by animals of several low-leukemia strains (CBA, I, A, C3H, NH) . Transfer of the young to foster mothers was effected within 24 hours after birth. The incidence of leukemia was somewhat lower than the expected 55 per cent in strain F animals, but the animals did not survive as long as unfostered strain F mice. Since the incidence of leukemia was as high in the offspring of these animals as in strain F controls, it is doubtful that this decreased incidence is to be considered significant.
A milk-influence has thus far been shown to be extremely potent only in the genesis of heritable mammary cancer in mice. Leukemia does not differ, therefore, from certain other neoplasms for which no milk-influence has been demonstrated. In no case has the maternal influence, as revealed by F1 hybrids, been shown to be as significant as it is in mammary cancer, where it may determine whether the incidence of tumors is 90 per cent or 5 per cent. The most significant difference was that demonstrated by MacDowell and Richter. In their experiments the life expectancy was considerably higher in F1 hybrids whose mother was of the low-leukemia strain. In these animals the incidence of leukemia was also lower and the age of onset was later. The decreased total incidence might conceivaEbly be explained on the basis of life expectancy, with, in this group, a greater chance for death from causes other than leukemia.
Diet: The incidence of methylcholanthrene-induced leukemia in sub-line 212 of strain dba was reduced from 90 to 10 per cent when the animals were fed a diet low in cystine.10' This amino acid is necessary for general body growth. However, body growth was restricted by feeding mice a diet low in lysine and the incidence of induced leukemia was still high.102 It is possible that cystine has a specific effect on neoplastic as differentiated from general growth. In the same strain and sub-line of mice caloric restriction delayed the onset and decreased the incidence of induced leukemia. 41 Furth has found that the incidence of spontaneous leukemia and the growth of transplanted leukemia can be inhibited 'by underfeeding.20 If transplanted into normal animals the lymph nodes of the underfed mice exhibited progressive leukemic growth, indicating that underfeeding does not inhibit neoplastic alteration per se. The incidence of leukemia was not significantly different in strain F mice fed diets high and low in fat; the latent period of carcinogenic induction was prolonged in strain dcba mice fed the high-fat diet, although the total incidence of leukemia was not decreased.55
Endogenous hormones: The incidence of leukemia is higher in the females of certain high-leukemia strains.'2 Administration of estrogens also resulted in the appearance of leukemia in certain lowleukemia strains.3" 32 Following ovariectomy the incidence of leukemia was reduced in the high-leukemia Ak stock.70 However, leukemia develops in both males and females of high-leukemia stocks, and there is nothing to suggest a significantly increased leukemia incidence in breeding as contrasted with virgin females; the incidence of carcinogen-induced leukemia was higher in virgin than in breeding females of the dba strain." Ovariectomy did not diminish the incidence of leukemia nor delay the onset of the disease in females of the F strain. 40 In neither the induced disease in strain dba7" nor the spontaneous disease in strain F was there evidence that the sex hormones influence the appearance of the disease.
Although a significant rOle of the adrenal in the growth of transplanted rat leukemia has been suggested,94 there is as yet no evidence that the onset of either spontaneous or carcinogen-induced leukemia is affected by adrenalectomy or by the administration of adrenalcortical extract. These problems should be investigated in view of the effect of adrenal cortex secretion on normal lymphopoiesis.4, 35, 88 The recently reported effect of thymectomy on the incidence of spontaneous leukemia70 is startling; in the Ak stock the incidence of the spontaneous disease was reduced from 60 to 8 per cent by this procedure. Either a primary neoplastic focus is being removed, or there is an endocrine effect. It is of interest that the thymus hypertrophies after adrenalectomy in the rat, and such animals were more susceptible to transplanted leukemia.94 It seems unlikely that the thymus would be the primary focus in such a large percentage of leukemias. In the C58 strain it proved not to be one of the primary foci.83 Although many mediastinal lymphosarcomas appear in the F strain, the primary growth seems to be in the perithymic mediastinal nodes rather than in the thymus itself. These results incidental to thymectomy are so intriguing because the theory of an endocrine function for the thymus has been rather generally discarded.
Transplantation studies It has not been possible to transfer'mammalian leukemia with tissue extracts or blood plasma passed through bacterial filters,2' 41, 86 and leukemia has not resulted from inoculation of fragments of ruptured cells.28 Engelbreth-Holm and Frederiksen'6 suggested that maintenance of anaerobic conditions during extraction of mammalian leukemic tissues preserved a potent filterable agent. In one series of experiments the onset of spontaneous leukemia in the C58 strain was hastened by injection of the cobalt-cysteine mixture used by Engelbreth-Holm in o(btaining anaercobic conditi'ons, but the existence of a virus involved in the passage of the disease could not be esta!blished.67 In general, mouse neoplasms grow in the strain of origin and in F, hybrids between this and a foreign strain.92 A variable num'ber of F2 hybrids are susceptible to transplantation. Mammary cancer or normal tissue of F, hybrids grew only in F, hybrids and in neither parent stock.7 This transplantation pattern was true for spontaneous leukemias of F, hybrids resulting from mating of the high-leukemia F strain and low-leukemia strains.47 Strain F leukemias growing in F, hybrids are readily transplanted into the strain F parent stock, indicating that the leukemic cells do not arise from F, hybrid tissue.4' Leukemias arising in hybrids between the Ak stock and low-leukemia stocks grew in the highleukemia parent stock, but not in the low-leukemia parents.87 Thus, in this case susceptibility to transplantation and to the spontaneous disease could be correlated.
Factors other than the genetic constitution of the recipient are concerned in the transplantation of at least certain lines of leukemia. When, after numerous passages, one line of leukemia of the C58 strain had become extremely malignant, it grew progressively in the StoLi strain which had previously been resistant. Leukemic cells will occasionally grow temporarily in untreated mice of a for- 58 eign strain. Irradiation of previously resistant mice induced susceptibility to inoculated cells.29' 5' Rats irradiated with x-rays have grown leukemic cells of the mouse."6 Foster-nursing of resistant mice has in certain instances made for susceptibility to transplantation.53 In the case of a line of rat leukemia, susceptibility has been increased by adrenalectomy previous to inoculation,94 and decreased by pre-transplantation injections of adrenal-cortical extract or adrenotrophic hormone. 76 The adrenals are perhaps concerned with the regulation of normal lymphopoiesis;4, 35 88 hyperplastic nodes would seem to provide a more favorable environment for transplanted cells. However, x-irradiation reduces resistance to transplantation and also causes the lymph nodes to become aplastic; consequently, the lymphocyte has also been implicated in active resistance to transplantation. 74 Although The more virulent the leukemia becomes, and the earlier death supervenes following transplantation, the less extensive are the lesions. Victor and Potter98 observed a marked drop in serum glucose in association with one line of transplantable leukemia of high malignancy. They were unable to relate this phenomenon to any particular mechanism causing death. The physiological characteristics of leukemic lymphocytes may be altered by transplantation. Lines of lymphocytes which produced leukemia with a blood picture have (been known to produce an aleukemic type of disease, or the reverse situation might hold.46 When the animal is moribund there is greater likelihood of an outpouring of leukemic cells into the blood. The "leukemic" and "sarcomatous" nature of lymphocytes has been discussed.
Metabolism of mouse leukemia
The metabolism of spontaneous, transmitted,'3' 97 and induced leukemia'0 resembles that of malignant tissue; the respiratory quotient is less than unity and the rates of both aerobic and anerobic glycolysis are greater than in normal lymph nodes. However, normal and leukemic nodes do not differ metabolically as widely as do normal and malignant tissues of other types; normal mouse lymph nodes possess a definite but not large anaerobic and aerobic glycolysis. The qualitative metabolic change exists, although the quantitative change is of low magnitude. The reports in the literature concerning the metabolism of human leukemic cells are conflicting39 (see Forkner). Arnow, Opsahl, and Watson were unable to extract racemic glutamic acid from a human leukemic spleen, although they considered d-glutamic acid to be characteristic of true neoplastic tissue.'
Experimental therapy
The effects of radium and x-irradiation on the growth of mouse leukemia have been tested experimentally. Only slight prolongation of life was observed when animals were inoculated with leukemic cells and then irradiated with x-rays29 or exposed to radium;27 systemic leukemia could not be cured. Administration of radioactive phosphorus had no influence on the course of transplanted lymphatic or myelogenous leukemia.56 Leukemic tissue had no greater content of phosphorus than normal lymphoid tissue, but the phosphorus exchange was greater than normal. The therapeutic effects of various sulfonamides and arsenicals, and of lbenzol, irradiation, and underfeeding were tested on the course of transplanted leukemia.18 Although benzol, irradiation, and underfeeding retarded the progressive growth of leukemic cells of certain lines, the life of inoculated animals was in general neither consistently nor strikingly prolonged. Colchicine, a so-called "radiomimetic" drug, and suramin, a non-arsenical trypanosomide, inhibited the growth of local lymphoid tumors temporarily.6" 103 Both colchicine and suramin were toxic in "therapeutic" doses. Administration of adrenal-cortical extracts or adrenotrophic hormone might conceivably inhibit the growth of lymphoid tumors, judging from the effect of cortical extract on normal lymphopoiesis.
Studies on therapy have been carried out on transplanted leukemia. Since the spontaneous disease is more comparable to human leukemia, it would seem desirable that investigations be made on cases of the spontaneous disease within a high-leukemia strain. Untreaited cases should serve as adequate controls. One of the difficulties in such experimentation, as in the case of clinical medicine, is that most cases are seen in the terminal. state. If there were a sure means of early diagnosis (in the C58 strain diagnosis has been made at the inception of the disease), then x-ray therapy would receive a more adequate test.
The average period of induction of leukemia with methylcholanthrene in strain dba (sub-line 212) is 90 to 100 days. After the administration of carcinogen for 60 to 70 days 'the animals received 960 r by fractional irradiation. 37 The date of onset of leukemia was not delayed by such treatment. Treatment of animals with spontaneous mediastinal lymphosarcoma with one dose of 360 r resulted in clinical improvement and prolongation of life, probalbly because of release of mediastinal pressure. Similar treatment of animals with systemic leukemia induced regression in the size of the spleen and lymph nodes; there was, however, subsequent enlargement. Survival was not longer than in control animals. Summary 1. Spontaneous leukemia occurs in a large proportion of mice of several inbred strains; the disease can be induced in others by various means. Thus, experimental material is available for study of the causation, diagnosis, and treatment of leukemia.
2. Mouse leukemia is probably the same disease as that seen in man. Experimental evidence is in favor of the neoplastic nature of the disease, all investigators of rodent leukemia being in agreement. Lymphosarcoma and leukemia would seem to be different morphological manifestations of the same fundamental disease proc-ess; the classification of a disease as "lymphosarcoma" or "leukemia" is in many cases arbitrary. Experimental work does not support the concept of "systemic" or multicentric origin of spontaneous leukemia, although carcinogen-induced leukemia may, as in the case of induced lung and breast tumors, have multicentric foci of origin appearing simultaneously.
3. It has not been possilble to transmit mammalian leukemia by inoculation of tissue extracts or blood plasma passed through bacterial filters, and leukemia has not resulted from inoculation of fragments of ruptured cells. Mammalian leukemia is transferable by inoculation of only viable leukemic cells into a susceptible host, usually of close genetic relationship. Factors other than genetic constitution (x-ray, partial immunization, adrenal hormones, increase in cellular malignancy) may modify transplantation in so far as growth per se or character of the leukemic growth is concerned. Immunity to transplanted leukemia has resulted from inoculation of sublethal doses of cells, injections of suspensions of normal tissue cells of certain genetic constitution, administration of heat-killed leukemic cells, ultracentrifuged leukemic cell extracts, or normal defibrinated blood. Immunity has been passively transferred by inoculation of liver and spleen of immune animals. It has not been possilble to immunize against either the spontaneous disease or the cells of a spontaneous case of leukemia.
4. Multiple agents can induce leukemia in mice; these are carcinogens, x-rays, estrogens, and the unknown stimulants responsible for the spontaneous disease. Mice of only certain genetic constitution are susceptible to only certain agents. Genetic susceptibility to one agent, or to the spontaneous disease, is not necessarily correlated with susceptibility to other leukemogenic agents. Synergists can condition the response to carcinogens, but their effectiveness varies with the strain of animals involved. 5 . Uniform results have not been obtained in studies on the genetics of mouse leukemia, the incidence of leukemia in hybrid crosses varying with the high-and low-leukemia strains used. Whether this discrepancy is apparent or real depends on whether or not the data of different investigators are comparable. The onset of leukemia is delayed in hybrid animals as compared with mice of the high-leukemia stocks. This delay could in one study be correlated with (1) the degree of inheritance from the high-leukemia stock and/or (2) the increased life expectancy in hybrids. The total percentage of leukemia was as high in certain hybrid crosses as in the pure stock. Leukemic cells differ genetically for each spontaneous case, as proven by transplantation experiments, the assumption being that somatic mutation is associated with neoplastic development. Transplantation patterns of carcinogen-induced leukemia suggest induction of somatic mutations which do not occur spontaneously.
6. The breast-milk of certain strains of mice has been reported to contain a material which influences the total incidence of leukemia in genetically susceptible animals. The material would seem not to be identical with the mammary cancer "milk-influence" nor as necessary for the development of "genetic" leukemia as is the latter for mouse mammary cancer of the "genetic" type. The influence which for the present is designated as "genetic" is the only one which thus far has been demonstrated as essential for tihe appearance of leukemia in successive generations of inbred mice.
7. Feeding of a diet low in cystine has resulted in a reduced incidence of carcinogen-induced leukemia. A diet low in lysine did not influence the induction of leukemia similarly, although general body growth was inhibited by deficiency of either amino acid. The incidence of death from spontaneous leukemia was lowered in a highleukemia strain of mice by underfeeding; neoplastic alteration per se was not inhibited, as demonstrated by progressive growth upon transplantation of lymph nodes of experimental animals into normal mice. Varying the amount of fat in the diet did not affect the onset of spontaneous leukemia; on a high-fat diet the induction time of methylcholanthrene-induced leukemia was prolonged. 8 . Although the incidence of leukemia is higher in females of certain strains, and large doses oT estrogens have been shown to be leukemogenic for certain mice, the importance of endogenous estrogen in the development of mouse leukemia would seem to be relatively minor, as compared, for instance, with the role of estrogens in mammary cancer development. Adrenal-cortical hormones might be involved in the development of leukemic lesions, absence of adrenal secretion having been reported to favor the growth of rat leukemic cells. It has not yet 'been determined whether inhibition of lymphopoiesis tby cortical extracts will affect the onset of either induced or spontaneous leukemia. Recent experiments suggest that the thymus gland might in some undetermined manner influence the development of spontaneous leukemia in mice.
9. The metabolism of mouse leukemic tissue qualitatively resembles that of malignant tissues, but the deviation from normal is of lesser magnitude.
10. Experiments on genesis and therapy of mouse leukemia have thus far yielded no suggestion for improving methods of early diagnosis or treatment of the human disease.
